U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H7NO3
Molecular Weight 153.1354
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-AMINO-3-HYDROXYBENZOIC ACID

SMILES

NC1=C(O)C=CC=C1C(O)=O

InChI

InChIKey=WJXSWCUQABXPFS-UHFFFAOYSA-N
InChI=1S/C7H7NO3/c8-6-4(7(10)11)2-1-3-5(6)9/h1-3,9H,8H2,(H,10,11)

HIDE SMILES / InChI

Molecular Formula C7H7NO3
Molecular Weight 153.1354
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
NO scavenging by 3-hydroxyanthranilic acid and 3-hydroxykynurenine: N-nitrosation leads via oxadiazoles to o-quinone diazides.
2008-11
Metabolic reconstruction of aromatic compounds degradation from the genome of the amazing pollutant-degrading bacterium Cupriavidus necator JMP134.
2008-08
Responses of differentiated MC3T3-E1 osteoblast-like cells to reactive oxygen species.
2008-06-10
Simultaneous measurement of tryptophan and related compounds by liquid chromatography/electrospray ionization tandem mass spectrometry.
2008-05-01
Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.
2008-05
Effect of 3-hydroxyanthranilic acid in the immunosuppressive molecules indoleamine dioxygenase and HLA-G in macrophages.
2008-04-15
Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase.
2008-04-15
Iron source preference and regulation of iron uptake in Cryptococcus neoformans.
2008-02-08
Cinnabarinic acid generated from 3-hydroxyanthranilic acid strongly induces apoptosis in thymocytes through the generation of reactive oxygen species and the induction of caspase.
2008-01-01
IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells.
2007-11
Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle.
2007-10
Altered kynurenine metabolism correlates with infarct volume in stroke.
2007-10
The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis.
2007-09
Effect of nicotinamide administration on the tryptophan-nicotinamide pathway in humans.
2007-07
Immunosuppressive effect of tryptophan metabolites in composite tissue allotransplantation.
2007-06
Mechanisms of copper ion mediated Huntington's disease progression.
2007-03-28
Crystal structure of Homo sapiens kynureninase.
2007-03-13
Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches.
2007-02-17
Mechanisms by which acyclovir reduces the oxidative neurotoxicity and biosynthesis of quinolinic acid.
2007-02-13
Kynurenines impair energy metabolism in rat cerebral cortex.
2007-02
Degradation of 2-nitrobenzoate by Burkholderia terrae strain KU-15.
2007-01
In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain.
2007-01
Fe(3+)- and Cu(2+)-reduction by phenol derivatives associated with Azure B degradation in Fenton-like reactions.
2007-01
[A short test for potential carcinogenicity of water soluble synthetic polymers].
2006-12-22
Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans.
2006-11
Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment.
2006-11
Pneumococcal meningitis causes accumulation of neurotoxic kynurenine metabolites in brain regions prone to injury.
2006-11
Acetylsalicylic acid and acetaminophen protect against oxidative neurotoxicity.
2006-09
Tryptophan metabolism in the central nervous system: medical implications.
2006-08-31
3-Hydroxyanthranilic acid, one of L-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells.
2006-08
Comparative EST analysis provides insights into the basal aquatic fungus Blastocladiella emersonii.
2006-07-12
Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.
2006-07
4-chloro-3-hydroxyanthranilate reduces local quinolinic acid synthesis, improves functional recovery, and preserves white matter after spinal cord injury.
2006-06
Crystal structure of 3-hydroxyanthranilic acid 3,4-dioxygenase from Saccharomyces cerevisiae: a special subgroup of the type III extradiol dioxygenases.
2006-04
Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines.
2006-02
Cloricromene effect on the enzyme activities of the tryptophan-nicotinic acid pathway in diabetic/hyperlipidemic rabbits.
2006-01-18
Tryptophan metabolism and oxidative stress in patients with chronic brain injury.
2006-01
Changes in the immune system in depression and dementia: causal or coincidental effects?
2006
Radical scavenging and catalytic activity of metal-phenolic complexes.
2005-12-22
The effect of age on the enzyme activities of tryptophan metabolism along the kynurenine pathway in rats.
2005-10
Profiling dendritic cell maturation with dedicated microarrays.
2005-09
Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for role of the kynurenine pathway in pregnancy.
2005-07
Structural studies on 3-hydroxyanthranilate-3,4-dioxygenase: the catalytic mechanism of a complex oxidation involved in NAD biosynthesis.
2005-05-31
The mechanism of inactivation of 3-hydroxyanthranilate-3,4-dioxygenase by 4-chloro-3-hydroxyanthranilate.
2005-05-31
Tryptophan metabolism and oxidative stress in patients with Huntington's disease.
2005-05
Tryptophan metabolites interfere with the Ehrlich reaction used for the measurement of kynurenine.
2005-04-01
The pyridine ring of NAD is formed by a nonenzymatic pericyclic reaction.
2005-01-26
Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo.
2005-01
Reduced serotonin and 3-hydroxyanthranilic acid levels in serum of cystatin B-deficient mice, a model system for progressive myoclonus epilepsy.
2005
Tryptophan loading induces oxidative stress.
2004-11
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:59:34 GMT 2025
Edited
by admin
on Mon Mar 31 18:59:34 GMT 2025
Record UNII
1UQB1BT4OT
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-AMINO-3-HYDROXYBENZOIC ACID
Systematic Name English
NSC-522891
Preferred Name English
ANTHRANILIC ACID, 3-HYDROXY-
Common Name English
3-HYDROXYANTHRANILIC ACID
Systematic Name English
2-AMINO-3-HYDROXY-BENZOIC ACID [HSDB]
Common Name English
Code System Code Type Description
NSC
522891
Created by admin on Mon Mar 31 18:59:34 GMT 2025 , Edited by admin on Mon Mar 31 18:59:34 GMT 2025
PRIMARY
EPA CompTox
DTXSID40203290
Created by admin on Mon Mar 31 18:59:34 GMT 2025 , Edited by admin on Mon Mar 31 18:59:34 GMT 2025
PRIMARY
CAS
548-93-6
Created by admin on Mon Mar 31 18:59:34 GMT 2025 , Edited by admin on Mon Mar 31 18:59:34 GMT 2025
PRIMARY
WIKIPEDIA
3-HYDROXYANTHRANILIC ACID
Created by admin on Mon Mar 31 18:59:34 GMT 2025 , Edited by admin on Mon Mar 31 18:59:34 GMT 2025
PRIMARY
PUBCHEM
86
Created by admin on Mon Mar 31 18:59:34 GMT 2025 , Edited by admin on Mon Mar 31 18:59:34 GMT 2025
PRIMARY
CHEBI
15793
Created by admin on Mon Mar 31 18:59:34 GMT 2025 , Edited by admin on Mon Mar 31 18:59:34 GMT 2025
PRIMARY
HSDB
4040
Created by admin on Mon Mar 31 18:59:34 GMT 2025 , Edited by admin on Mon Mar 31 18:59:34 GMT 2025
PRIMARY
FDA UNII
1UQB1BT4OT
Created by admin on Mon Mar 31 18:59:34 GMT 2025 , Edited by admin on Mon Mar 31 18:59:34 GMT 2025
PRIMARY
DRUG BANK
DB03644
Created by admin on Mon Mar 31 18:59:34 GMT 2025 , Edited by admin on Mon Mar 31 18:59:34 GMT 2025
PRIMARY
ECHA (EC/EINECS)
208-962-5
Created by admin on Mon Mar 31 18:59:34 GMT 2025 , Edited by admin on Mon Mar 31 18:59:34 GMT 2025
PRIMARY
MESH
D015095
Created by admin on Mon Mar 31 18:59:34 GMT 2025 , Edited by admin on Mon Mar 31 18:59:34 GMT 2025
PRIMARY